Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. - Wikidata - awgldk - TriplyDB

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

http://www.wikidata.org/entity/Q34307399

about

Cloning and characterization of novel mouse and human secretory phospholipase A(2)s p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling Alkylglycerol monooxygenase To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention The functional implications of the dimerization of the catalytic subunits of the mammalian brain platelet-activating factor acetylhydrolase (Ib)Crystal Structure of Human Plasma Platelet-activating Factor Acetylhydrolase: STRUCTURAL IMPLICATION TO LIPOPROTEIN BINDING AND CATALYSIS The role of platelet-activating factor in mesangial pathophysiology Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations Phospholipase A2 biochemistry Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein Hydrolysis of platelet-activating factor by human serum paraoxonase The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain Targeted disruption of intracellular type I platelet activating factor-acetylhydrolase catalytic subunits causes severe impairment in spermatogenesis On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes Phospholipin, a novel heterodimeric phospholipase A2 from Pandinus imperator scp6pion venom.The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature Lp-PLA2 Inhibition-The Atherosclerosis Panacea?Phospholipase A2: its usefulness in laboratory diagnostics.Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma Events at the vascular wall: the molecular basis of inflammation.Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasion PAF acetylhydrolase gene polymorphisms and asthma severity.The emerging roles of PAF acetylhydrolase.Bacterial clearance is improved in septic mice by platelet-activating factor-acetylhydrolase (PAF-AH) administration.Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways.Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy.The metabolic serine hydrolases and their functions in mammalian physiology and disease.

P2860

Q22003814-E8ED627C-B9FC-4016-BA6F-27B17B4516D6 Q24319291-C816DBDC-4695-4357-AB01-A8EA301B823E Q24321607-7D8FEDFE-32B6-4A99-9BE8-71D81D3F8E6C Q24336429-71A980FF-96AC-4725-BEE8-CB72787D615F Q24530703-86838E8F-28C8-4893-A1FE-99C26A8B8736 Q24540170-C878F7C7-1E0A-43AB-9EA4-1E2DF109335A Q24542068-CC6A193F-AE4F-4B5C-8571-502C3379D63A Q24562119-B939ACE9-7F2C-4499-82B3-3E584236E6C3 Q24658561-5FBA3122-7894-45DE-BA11-CC9518F27A16 Q26825422-6C030A3D-5AEE-4D3D-9DB0-C3D799CA1A8A Q26865969-2CDCBAB3-EC66-4F94-AAE5-3081F4243508 Q26997377-BD898E5C-F9CF-4016-BDFE-58DA85590CE6 Q27630395-562A9ADA-33F7-4088-819F-8841D52ACFF5 Q27652078-03BB9205-4E9A-4D11-B21C-D864CE279AFA Q28081511-DEA3312C-74BE-4EE0-AC8B-85C5EEF4FEDC Q28286551-F0230CEF-FD32-460C-B10E-BE3866BED6A7 Q28297979-95190FB7-116F-413A-80A7-F313EF8F0EE2 Q28301551-8ABC0FA4-702D-410E-86EB-C4D9DE4E7E88 Q28347908-2C9460CD-A6CC-4D90-9314-340C741F9DBD Q28362314-0355BE3F-0E3C-4415-8416-A6F7AAF8AA73 Q28389004-6E6D494B-EFF3-46F5-9621-3AA5A88F302B Q28512042-862CE780-CFDD-40D7-AF44-92A2EB3EEADE Q28581954-247BC83E-1886-4C56-BCD9-53F2574C7ACE Q28588411-3EA08DFA-284F-4B03-86DB-BFAE04834529 Q28592582-718565E0-8C65-4E82-A5C2-7C6F12ED2FD4 Q30810564-206FE30F-D0EE-4B9F-BB2D-4D31EDB4459D Q33490130-7B2629C9-8697-413B-8B6A-6894B8F2B6D7 Q33536648-17522F08-3393-4A7B-B498-393784F46D9F Q33664272-D6711447-AEE3-4DB6-A0D9-8EB682AEA81A Q33702391-A678CE83-1E77-4953-BB6D-7ADA2B9DB535 Q33805731-9EC6C8BE-F2E0-4073-8502-C1571A527B13 Q33848692-32694721-59A0-47C4-B147-84A04689338E Q34161044-B51A947B-24D9-4FC8-BB69-09B8C934E13E Q34229649-4A0A2023-BFAE-40A0-BDB7-135E081D738B Q34355213-BBD97681-398C-4783-8398-4AB60102FAED Q34847192-4C82D26F-EF92-44C4-8E72-5BBF9C6BA25E Q34999226-2A2A80E9-C088-4BF9-ACBD-501F02765C9D Q35099704-C0C5B552-68EA-47D9-A717-DE2E7E761E31 Q35233027-F3AF020C-B8BE-4C59-82B9-8BA6E92D9B15 Q35333042-47A2CED6-B0D6-4E5F-91B0-495FAFA5F56A

P2860

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

http://www.wikidata.org/entity/Q34307399

description

1995 nî lūn-bûn

@nan

1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@ast

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@en

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@nl

type

label

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@ast

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@en

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@nl

prefLabel

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@ast

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@en

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@nl

P1433

Q34307399-227077FA-87D9-444D-839F-AC8AB8CB9536

P1476

Q34307399-B23B4307-0D78-43F2-9295-F57C705BB929

P2093

Q34307399-061CAC58-D2AB-461B-A04C-AE5AB9CC0650

Q34307399-07B00351-84D1-4B4F-866E-9C078A6EAF0F

Q34307399-090AD8F1-FFA9-404E-9972-380D6BAF2053

Q34307399-26406177-B055-4583-A9F2-EA887D5BDBFB

Q34307399-34B2B845-89E3-4D73-8144-F27F128A1D8A

Q34307399-5D81B6E1-EB58-4690-935F-DC000645838B

Q34307399-66A6CBDA-A812-4295-9D1F-98F4D9B160E8

Q34307399-6F0C75C5-4A6C-42B2-8F71-52C0BFD20856

Q34307399-80694A7C-AA3C-4760-B024-E71CDF00C214

Q34307399-8A4C2478-2D00-45B5-81F3-CBFFBD0E9495

P2888

Q34307399-937ABB9E-4F0E-493F-A2C8-9E9B90108F74

P304

Q34307399-A84B0752-4DC1-429D-8C93-282C7BD24B7A

P31

Q34307399-A0C9CE5B-B29B-4AC3-9929-EBC0FBE08BDE

P356

Q34307399-27677BB0-A1AF-42E3-A3F1-DF4594899829

P407

Q34307399-110A31F7-15CE-468E-86A9-6FC45D6662C1

P433

Q34307399-6CC974DD-C538-4022-AFED-42202FDEE03C

P478

Q34307399-83EFB3E0-5820-49D1-8CC3-1A975BDC1F05

P577

Q34307399-1B7CF308-9E69-47FB-8889-54E316EBFE4E

P6179

Q34307399-9193A6C5-298F-4668-9EA2-339445D801B5

P698

Q34307399-2D3D3184-0973-41B7-A292-960AA35DD1FE

P921

Q34307399-6263967A-0D84-4373-893E-F6D36554069B

Q34307399-F4351CE8-D741-4435-B5B3-539C3F78956D

P356

P1433

P1476

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

@en

P2093

B Schimpf

http://www.w3.org/2001/XMLSchema#string

C Eberhardt

http://www.w3.org/2001/XMLSchema#string

C Wilder

http://www.w3.org/2001/XMLSchema#string

D M Stafforini

http://www.w3.org/2001/XMLSchema#string

G A Zimmerman

http://www.w3.org/2001/XMLSchema#string

G Dietsch

http://www.w3.org/2001/XMLSchema#string

H Le Trong

http://www.w3.org/2001/XMLSchema#string

L S Cousens

http://www.w3.org/2001/XMLSchema#string

L W Tjoelker

http://www.w3.org/2001/XMLSchema#string

P W Gray

http://www.w3.org/2001/XMLSchema#string

P2888

P304

549-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/374549A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

6522

http://www.w3.org/2001/XMLSchema#string

P478

374

http://www.w3.org/2001/XMLSchema#string

P577

1995-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038734170

http://www.w3.org/2001/XMLSchema#string

P698

7700381

http://www.w3.org/2001/XMLSchema#string

P921

2-O-glutaroyl-1-O-palmitoyl-sn-glycero-3-phosphocholine(1-)